Clinically Proven Care for Dry Age-Related Macular Degeneration
MacuMira is Canada’s first clinically proven, regulatory-approved treatment for dry age-related macular degeneration (AMD). This noninvasive light therapy is designed to help restore lost vision and improve your quality of life.
Dry AMD can make everyday tasks like reading, driving, and recognizing faces more difficult. MacuMira offers a safe, comfortable, and effective way to target the root causes of vision loss and support your retinal health.
If you’re living with dry AMD, MacuMira may offer the relief and results you’ve been waiting for. We offer MacuMira at our InVision Eyecare location. Ask your optometrist for more information.
What Is Dry AMD?
Dry AMD is a progressive eye condition that damages the macula, the part of your retina responsible for sharp, central vision. It is one of the leading causes of vision loss in adults over 50.
In its early stages, dry AMD may not cause noticeable symptoms. As it develops, it can lead to:
- Blurry or distorted central vision
- Difficulty seeing in low light
- Reduced colour clarity and contrast sensitivity
MacuMira has been shown to help reverse some of this damage and support long-term macular health.
Benefits of MacuMira
MacuMira can help you:
- Improve central vision: Clinical trials showed vision improvements in all participating patients
- See more clearly in low light: Many patients report better contrast sensitivity and night vision
- Experience results quickly: Some patients notice changes within the first 10 days
MacuMira is designed for patients with early or intermediate dry AMD. If you have been told there is no treatment for your condition, this noninvasive therapy may be a promising option.
Is MacuMira Right for Me?
MacuMira is not suitable for everyone, and a proper eye examination is required to determine eligibility. For example, MacuMira is not effective for those with wet AMD.
This treatment may be considered for patients who:
- Have a confirmed diagnosis of dry age-related macular degeneration
- Are in the early to intermediate stages of the condition
- Have noticed gradual changes in central vision related to AMD
- Are seeking noninvasive options as part of their eye care plan
A comprehensive assessment at Brighton Eyecare will help determine whether MacuMira is appropriate for your specific needs.
What to Expect During MacuMira Treatment
The treatment is comfortable and noninvasive and involves no injections or medications. The treatment uses a specialized headset that gently delivers microcurrent stimulation to your closed eyes.
Your eye care provider will create a personalized plan, typically starting with four sessions over 10 days, each lasting about 30 minutes.
During treatment:
- You’ll be seated comfortably in an exam chair
- The headset will be placed on your head
- The microcurrent enhances blood flow to nourish the macula and stimulates the production of essential cellular components that support retinal health
To maintain the benefits of the treatment, you’ll typically have follow-up sessions every 2.5 to 3 months.
Ask About MacuMira for Dry AMD
Looking for noninvasive treatment options for dry age-related macular degeneration (AMD)? Luminus Vision Group offers MacuMira at our InVision Eyecare location in Saskatoon.
If you’re interested in learning whether MacuMira is right for you, speak with your optometrist during your next eye exam. They can assess your eyes and, if appropriate, refer you to our InVision team for further care.
Frequently Asked Questions About MacuMira and Dry AMD
MacuMira is a Health Canada-licensed, noninvasive therapy engineered to help manage vision loss and support visual function in individuals diagnosed with dry age-related macular degeneration (AMD). We encourage you to book an appointment at Brighton Eyecare to receive a comprehensive evaluation and tailored advice on whether this treatment is suitable for your eyes.
MacuMira delivers gentle, low-level microcurrent stimulation through closed eyelids to target compromised cells within the macula. This targeted stimulation boosts cellular ATP production, improves microcirculation, and helps promote the clearance of cellular waste beneath the retina.
No, MacuMira does not cure dry AMD, as age-related macular degeneration remains a chronic and progressive condition. However, it is clinically shown to help support retinal health and can improve visual clarity and contrast sensitivity over time.
Each in-office treatment session lasts approximately 30 to 35 minutes and requires no recovery downtime once finished. A standard protocol typically begins with four brief visits completed within a 10-day period, followed by maintenance sessions every two to three months.
Yes, MacuMira is a painless, gentle procedure that involves no injections, medications, or surgical incisions. Patients rest comfortably with their eyes closed during the session and can immediately resume their daily activities afterward.
MacuMira is generally recommended for individuals in the early to intermediate stages of dry AMD who want a proactive option to preserve central vision. Book an appointment with our optometry team today to receive a comprehensive evaluation and tailored advice regarding your dry AMD care plan.
Visit Our Location
Find us in Brighton Marketplace, near the Shoppers Drug Mart and the Pet Valu. There is plenty of parking available.
Our Address
Contact Information
- Phone: 306-978-2993
- Fax: 306-978-2990
- Email: becadmin@yxevision.ca
After Hours Emergencies: 306-371-9911
Hours of Operation
Check Out
Brighton Eyecare
See What Our Patients Are Saying
